Cachexia in cancer - Zeroing in on myosin

被引：37
作者：
Chamberlain, JS [1 ]
机构：
[1] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Senator Paul D Wellstone Muscular Dystrophy Coope, Seattle, WA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 20期
关键词：
D O I：
10.1056/NEJMcibr042889
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2124 / 2125
页数：2
相关论文
共 4 条
  • [1] Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
    Acharyya, S
    Ladner, KJ
    Nelsen, LL
    Damrauer, J
    Reiser, PJ
    Swoap, S
    Guttridge, DC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) : 370 - 378
  • [2] Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression
    Bergstrom, DA
    Penn, BH
    Strand, A
    Perry, RLS
    Rudnicki, MA
    Tapscott, SJ
    [J]. MOLECULAR CELL, 2002, 9 (03) : 587 - 600
  • [3] Cancer cachexia: Its correlations and causes
    Rubin, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) : 5384 - 5389
  • [4] Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
    Sandri, M
    Sandri, C
    Gilbert, A
    Skurk, C
    Calabria, E
    Picard, A
    Walsh, K
    Schiaffino, S
    Lecker, SH
    Goldberg, AL
    [J]. CELL, 2004, 117 (03) : 399 - 412
1